Preparation and application of liposome-incorporated oligodeoxynucleotides.
Tari
A M
AM
Department of Bioimmunotherapy, University of Texas MD Anderson Cancer Center, Houston 77030, USA.
D000818:Animals; D001483:Base Sequence; D004337:Drug Carriers; D005456:Fluorescent Dyes; D018922:HL-60 Cells; D006801:Humans; D007202:Indicators and Reagents; D020014:K562 Cells; D007668:Kidney / Q000187:drug effects; D008081:Liposomes; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D008856:Microscopy, Fluorescence / Q000379:methods; D020319:Oligodeoxyribonucleotides, Antisense / Q000138:chemical synthesis* / Q000493:pharmacokinetics* / Q000494:pharmacology; D010761:Phosphorus Radioisotopes; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D011865:Radioisotope Dilution Technique; D051381:Rats; D011917:Rats, Inbred Lew; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured
D004337:Drug Carriers; D005456:Fluorescent Dyes; D007202:Indicators and Reagents; D008081:Liposomes; D020319:Oligodeoxyribonucleotides, Antisense; D010761:Phosphorus Radioisotopes